Phio Pharmaceuticals CEO Robert J. Bitterman reports purchase of $10,600 in common shares
PHIO•CEO makes open-market purchase
Phio Pharmaceuticals Chairman, President, CEO Robert J. Bitterman bought 10,000 common shares in an open-market purchase at $1.06 each.
Beneficial ownership increased to 431,421 common shares following the trade.
